Cite
HARVARD Citation
Guolo, F. et al. (n.d.). High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk‐oriented consolidation: A critical review of a 10‐year, single‐center experience in younger, non M3 AML patients. American journal of hematology. 91 (8), pp. 755-762. [Online].